Dan Udrea
Child & Adolescent Psychiatry · Wexford, PANPI 1104072800
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $41,610 of the $51,081 with a category attached, or 81.5%. Supernus Pharmaceuticals, Inc. accounts for 84.8% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $43,671, more than ten times the $34 reported in 2020. Among child & adolescent psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 331 payments — averaging $154.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$43K
- Corium, LLC$5K
- Takeda Pharmaceuticals U.S.A., Inc.$618
- Ironshore Pharmaceuticals Inc.$599
- Tris Pharma Inc$417
- Johnson & Johnson$400
- plus $794 from 12 others
What the payments were for
- Consulting fees$7201%
- Speaking & faculty fees$41,61081%
- Travel & lodging$3,2346%
- Food & beverage$5,48911%
- Education$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 112 | $43,341 |
| Corium, LLC | 54 | $4,912 |
| Takeda Pharmaceuticals U.S.A., Inc. | 57 | $618 |
| Ironshore Pharmaceuticals Inc. | 32 | $599 |
| Tris Pharma Inc | 12 | $417 |
| Johnson & Johnson | 16 | $400 |
| Collegium Pharmaceutical, Inc. | 13 | $211 |
| AbbVie | 7 | $131 |
| Neos Therapeutics, LP | 6 | $107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $98 |
| Vertical Pharmaceuticals, LLC | 5 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Avion Pharmaceuticals | 2 | $32 |
| Neuronetics, Inc. | 2 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$41,715
- Azstarys$4,183
- Quillivant$235
- SPRAVATO$103
- JORNAY PM$103
How this compares
$51,081 in reported general payments places this provider in the 95th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
See all child & adolescent psychiatry providers in Pennsylvania →
Other child & adolescent psychiatry in Wexford
- Leah WarcholWexford$1K
- Dennis BorczonErie$120K
- Suzanne LucotCranberry Township$72K
- Robert WilsonErie$34K
- Craig FeasterState College$18K
- Thomas WindPhiladelphia$17K
- Laura AdangPhiladelphia$15K
- Christoph LamPhiladelphia$13K
- Raman BawejaHershey$11K
- Jeffrey HermannYork$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.